…a nobody’ patient Working with (and around) the system to ensure safe pregnancies of Russian women who use drugs Alexandra Julia Volgina Godunova.

Slides:



Advertisements
Similar presentations
The JJ Way® An MCH System of Care Jennie Joseph LM, CPM Founder, Executive Director.
Advertisements

Follow-up after training and supportive supervision The IMAI District Coordinator Course.
European Guidelines for the HIV Treatment Esteban Martínez Infectious Diseases Unit Hospital Clínic University of Barcelona Barcelona SPAIN.
John N. Lavis, MD, PhD Professor and Canada Research Chair in Knowledge Transfer and Exchange McMaster University Program in Policy Decision-Making McMaster.
Strategies and Interventions for Community-Based Organizations Implementing HIV Prevention Joseph Prejean, Ph. D. Capacity Building Branch Division of.
Part A: Module A5 Session 2
Fact sheet Policies and Programs to Address Drug-Exposed Newborns The use or abuse of either illegal or prescription drugs during pregnancy can have serious.
Maternal and Newborn Health Training Package
Caring for the “Compound” Patient: Ethical Challenges and Practical Advice for Obstetricians [Insert Name of Presenter] Ethics Resource Center American.
After the Rapid Policy Assessment (RPAR): Drug Policy Change and Advocacy in Szczecin, Poland Sobeyko J (1), Leszczyszyn-Pynka M (2), Duklas T (7), Parczewski.
Office of Global Health and HIV (OGHH) Office of Overseas Programming & Training Support (OPATS) Maternal and Newborn Health Training Package Session 11:
“Humanitarian Action” The Saint-Petersburg Charitable Foundation for Medical and Social Programs HAF.
Brandi Cooke Student Intern 3 rd National Summit on Preconception Health and Health Care June 12-14, 2011 Factors Affecting the Willingness of Counselors.
University of Hawai’i Integrated Pediatric Residency Program Continuity Care Program Medical Home Module Case 3.
Improving Maternal and Perinatal Outcomes in North Carolina Patti Forest, MD Medical Director Division of Medical Assistance.
Problems in Birth Registration What is the National Standard? Why is the data so important? Joanne M. Wesley Office of the State Registrar.
Community Based Approaches: A review of intervention models and evidence of their effectiveness for preventing maternal-to-child transmission of HIV Joanna.
A Presentation to __________ Healthy Timing and Spacing of Pregnancy (HTSP): For healthy babies, healthy mothers, and healthy communities.
THE PREVENTION OF MOTHER TO CHILD TRANSMISSION of HIV (PMTCT)
Early Childhood Development HIV/AIDS in Malawi
RHEA Phase 1 Storyboard. Purpose This provides a high level overview of the solution, in a simple story format.
The introduction of social workers in the primary health care system and its impact on the reduction of baby abandonment in Kazakhstan 10 September 2014,
National Capital Strong Start
African Americans and HIV: CA Office of AIDS Response Michelle Roland, MD Chief, Office of AIDS California Department of Public Health.
HIV in Suriname Ministry of Health Suriname M.Sigrid Mac Donald – Ottevanger, MD Focal point HIV Treatment and Care, NAP.
Improving Early ANC Attendance: Project ACCLAIM Mary Pat Kieffer, Godfrey Woelk, Daphne Mpofu, Rebecca Cathcart and the ACCLAIM Study Group.
DON’T FORGET THE ‘E’ IN “MORPHINE” International Pain Policy Fellowship: Advocacy & Communications.
1 Promotoras, Peer Participant Providers and Community Outreach as Preconception in the Continuum of Perinatal HIV Transmission Armida Ayala, M.H.A., Ph.D.
Re-Considering Addiction Treatment How Can Treatment be More Accountable and Effective? Lessons from Mainstream Healthcare.
Integrated Health Programs for Women and Children: Lessons from the Field Dr. Ambrose Misore Project Director, APHIA II Western, PATH’s Kenya Country Program.
What is B’more for Healthy Babies?
Sarah A. Redding, MD, MPH Executive Director Community Health Access Project Mansfield, Ohio.
CDC’s Preemie Act Activities Wanda Barfield, MD, MPH, FAAP Director, Division of Reproductive Health National Center for Chronic Disease Prevention and.
PREVENTION OF VERTICAL TRANSMISSION OF HIV: THE FAMILY CENTRED AND COMMUNITY BASED APPROACH IN PERI-URBAN ZAMBIA Presented by Beatrice Chola Executive.
Components of a national drug prevention system Ms. UNODC.
Orientation on HIV care and ART Recording and Reporting System.
DOING PRECONCEPTIONAL HEALTH: LOCAL REALITIES Marjorie Angert, D.O., MPH, Director of Medical Affairs, Division of Maternal, Child and Family Health, Philadelphia.
Lesson 5 Public opinion polls and national surveys clearly show that most Americans have taken a stand against illegal drugs. Living Drug Free.
Origin and Process of Utah Guidelines Anna Fondario, MPH Utah Department of Health Violence and Injury Prevention Program.
Joanne Armstrong, MD, MPH A Health Plan’s Approach to Translating Research Findings into Practice 17 Alpha-Hydroxyprogesterone Caproate.
A GP for Me Making it Work in Victoria November 27, 2013.
Strategic assessment of policy, quality and access to contraception and abortion services in Macedonia Main findings 2007/08.
MAMA+ Comprehensive Support to HIV-positive Mothers with Young Children Roman Yorick, MD, MPH HealthRight International.
Module 2: Learning Objectives
Incorporating Preconception Health into MCH Services
DCHC MAT/ STOP HIV Collaborative Team. Improvement: Lost To Care Engagement  Improvement relates to: identifying, referring and re-engaging those lost.
Godunova Julia Executive director. We are the first and only network, created for the protection and support of women, who live with HIV and other socially.
Innovations and new initiatives to prevent obesity NSW Health Innovation & Health Symposium – November 2015 Louise A Baur University of Sydney: Discipline.
1 December 8, 2015 Crista M. Taylor, LCSW-C Director, Information, Planning and Development Adrienne Breidenstine, MSW Director of Opioid Overdose Prevention.
Reproductive Health class#2 Safe motherhood. Women’s Health Key facts.
Sub module 3 Pre-ART and ART registers. Purpose of registers Key individual information for: Facilitating patient management by the identification of.
Addressing the drug affected infant population and tools to end destructive cycles  Amy Baumann- BSW- Safe Babies Healthy Families  Colleen Allen- MSW,
Effective HIV & SRH Responses among Key Populations Module 3: Engaging Key Populations with HIV and SRH Services.
PMTCT - The Platform for integrating HIV/AIDS Services in the MCH Clinic. Bola Oyeledun, MD, MPH Track 1.0 Partners Meeting Washington DC. August 2008.
Corporate slide master With guidelines for corporate presentations Child Measurement Programme Third annual report – 19 May 2015 Welsh Government – the.
Reducing health inequalities among children and young people Director of Public Health Report 2012/13.
Provider Initiated HIV Counseling and Testing Unit 2: Introduction and Rational for PIHCT.
Konstantin Lezhentsev, MD All-Ukrainian Network of PLWHAS Organizing access to care and treatment for marginalized groups in Ukraine.
Chapter 5-3 Childbirth Options.
Module 4: Engaging KPs with HIV and SRH Services
Quality Improvement An Introduction
What is the Healthy Baby Program?
COLLECTIVE IMPACT APPROACH TO ADDRESSING
MOTHER TO CHILD TRANSMISSION of HIV
By Nour Elhouda Ata Alla Assistant Professor, Consultant Paediatrician
Experiences of the Russian Red Cross in Providing Medical/Psychological Assistance to HIV+ women and Children born to HIV+ mothers Irkutsk City (East Siberia)
The Last Mile to EMTCT: Are we there yet?
Lost in transition: Challenges in domestic financing for HIV and human rights 24 July E : :00.
Public/Population Health Approach to Substance Abuse Prevention & Treatment Determine the Burden of Substance Abuse and Service Barriers to Develop Plan.
HUMAN IMMUNODEFICIENCY VIRUS (HIV) PREVENTION & CARE
Presentation transcript:

…a nobody’ patient Working with (and around) the system to ensure safe pregnancies of Russian women who use drugs Alexandra Julia Volgina Godunova

Who are we? EVA 8 organizations and 267 individuals in 18 Russian regions working to improve the lives of women affected by HIV, TB, and drug use

Women who use drugs, Russia from 9% to 68% live with HIV 60-66% have Hepatitis C Age ranging from 17 to 55, average: 24 How many pregnant women have history of drug use? 60,000 inject drugs

What is going on with pregnant women who use drugs? How does the system address their unique needs? Who is responsible? Whose patient is the pregnant woman who uses drugs?

Project Goal: documenting evidence for policy change Data: 3-year study o , 6 cities: - survey of 213 women, - documentation of 32 cases o , 3 cities: - stakeholder analysis (23 in-depth interviews), - analysis of medical regulations, - documentation of best practices

Findings: intrinsic barriers …

Intrinsic barriers Fear and guilt Poverty Social isolation Chaotic lifestyle Distrust in healthcare system  Targeted outreach  Providing basics: food, clothing, refuge  Peer support  Addressing myths and fears

Findings: system-wide barriers …

Healthcare services fragmented (specialized and geographically scattered), high-threshold (ID, residency registration, and insurance required; waiting lines) System-wide barriers Drug addiction treatment limited options for rapid detox, opioid agonist maintenance therapy not available, no options for long-term residential care Regulatory framework standards of care for pregnant women who use drugs unavailable; gaps between WHO and Russian guidelines, no guidance on managing pregnant women with multiple conditions (drug use, STD, HIV, cardiovascular disease)

 Inadequate prenatal care Only 40% had the required number of prenatal visits; 27% - once or never  Late initiation of ARV On average, PMTCT started at 6 th month of pregnancy Only 74% women with HIV received ARV PMTCT, of them 48% were not fully adhered to the regimen; Consequences…

 Unaddressed drug addiction problem during pregnancy 88% attempted to stop/reduce drug use or switch to less harmful use Only 35% were able to completely withdraw through medical or self-imposed detox 10% sought, but could not secure residential care Lack of relapse prevention intervention at post-delivery stage

 “Nobody’s patient” Medical care is split into parts: each part is trying to do something, but no single structure is ultimately responsible for the patient Referring without monitoring = sending the woman into the abyss Offering less care in the absence of standards Offering less care because of judgmental attitudes/fears/dislikes of drug-using women

 Preventable complications and poor pregnancy outcomes 29% had miscarriage 8% had preterm delivery followed by neonatal death

Findings: local solutions

St. Petersburg, Tomsk, Naberezhnye Chelny

Working with and around the system! Intense outreach Ongoing case- management Education Food and clothing Physicians’ training Building a network of trusted physicians Interdisciplinary team coordination Referrals among clinical settings, NGOs, and rehab centers

Outcomes, services St. Petersburg, women Prenatal care visits once per every 1.5 months of pregnancy (compared to just 2 visits for pregnant women non-clients) Tomsk, women Enrolled in prenatal care at 8th-12th weeks of gestation (comparable with city-wide indicators for pregnant women who do not use drugs) Naberezhnye Chelny, women 12 babies, gestational age (mean): weeks (91% - between 36 and 40 weeks), birth weight: (mean): 2,740 gram

Outcomes, advocacy St. Petersburg City-supported ‘crisis apartment’ for pregnant women and new mothers who use drugs Tomsk Protocol on managing drug dependent women through pregnancy, childbirth, and early motherhood Naberezhnye Chelny Local ordinance to monitor and support each case of pregnant drug dependent woman

Next steps: work with the system Analyze, document, and disseminate best practices Educate decision makers and medical community and find potential champions Consolidate advocacy strategies at the local and country-wide level Work with local partners to improve their capacity Work with public opinion and engage media

Public opinion and mass media Training physicians Working with authorities

Our present A pregnant woman who uses drugs can only rely on herself An OB/GYN provider will send her to a drug addiction doctor Detox will put her at risk of miscarriage The woman will try to stop using on her own, but will likely relapse Our vision A pregnant woman who uses drugs can count on help of many professionals: counselors, social workers, drug addiction doctors, and OB/GYN doctor Assistance will be tailored to the woman’s individual situation and specific needs Happy mothers and healthy babies